The levels of vascular endothelial cells and endothelium-dependent vasomotor cytokines in children with essential hypertension: a case-control study - Report - MDSpire

The levels of vascular endothelial cells and endothelium-dependent vasomotor cytokines in children with essential hypertension: a case-control study

  • By

  • Jingjing Ma

  • Yaxi Cui

  • Yao Lin

  • Yanyan Liu

  • Yang Liu

  • Lin Shi

  • June 18, 2026

  • 0 min

Share

Clinical Report: Assessment of Circulating Endothelial Cells in Pediatric Hypertension

Overview

This study evaluates circulating endothelial cells (CECs), endothelial progenitor cells (EPCs), and endothelium-dependent vasomotor cytokines in children with essential hypertension. Significant differences in these markers were observed compared to healthy controls, indicating potential endothelial dysfunction in pediatric hypertension.

Background

Cite specific studies that highlight the gap in research on pediatric hypertension.

Data Highlights

ParameterHTN GroupControl GroupP-value
CECsHigherLower< 0.01
EPCsLowerHigher< 0.01
NO2−LowerHigher< 0.01
6-keto-PGF1aLowerHigher< 0.0001
ET-1HigherLower< 0.0001
TXB2HigherLower< 0.001

Key Findings

  • CECs were significantly elevated in children with essential hypertension compared to controls.
  • EPCs were significantly reduced in the hypertensive group.
  • Levels of NO2− and 6-keto-PGF1a were significantly lower in hypertensive children.
  • ET-1 and TXB2 levels were significantly higher in the hypertensive group.
  • Negative correlations were found between NO2−, 6-keto-PGF1a, and mean arterial pressure.
  • Positive correlations were observed between ET-1, TXB2, and mean arterial pressure.

Clinical Implications

The findings suggest that monitoring CECs and EPCs, along with vasomotor cytokines, may be crucial for early detection and management of endothelial dysfunction in pediatric hypertension. These markers could serve as potential targets for therapeutic interventions and risk stratification.

Conclusion

Alterations in endothelial markers in children with essential hypertension highlight the importance of endothelial dysfunction in its pathogenesis. Further research is warranted to explore these findings and their implications for clinical practice.

Related Resources & Content

  1. Pediatric Cardiology, 2018 -- Renalase Concentrations in Adolescents Diagnosed with Primary Hypertension
  2. American Journal of Epidemiology, 2025 -- Expert Commentary: Highlighting Concerns Regarding Hypertension in Pediatric Populations
  3. Pediatric Cardiology, 2022 -- Markers of Platelet Activation in Pediatric Patients with Congenital Heart Disease-Related Pulmonary Arterial Hypertension
  4. Pediatrics, 2024 -- Pediatric and Adolescent Hypertension: A Multidisciplinary Call to Action
  5. PMC, 2025 -- Elevated Blood Pressure and Cardiac Mechanics in Children and Adolescents: A Systematic Review and Meta-Analysis
  6. The Journal of Clinical Endocrinology & Metabolism — Cross-Site Evaluation of Cardiometabolic Diagnoses in Young Individuals with Congenital Adrenal Hyperplasia: Insights from a PEDSnet Study
  7. Pediatric and Adolescent Hypertension: A Multidisciplinary Call to Action
  8. Elevated Blood Pressure and Cardiac Mechanics in Children and Adolescents: A Systematic Review and Meta-Analysis - PMC
  9. Frontiers | Pulmonary arterial hypertension in children with congenital heart disease: a deeper look into the role of endothelial progenitor cells and circulating endothelial cells to assess disease severity

Original Source(s)

Related Content